Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

EXPLAINED: Is zimmer biomet stock underperforming the s p 500 - The Real Truth

With a market cap of $17.1 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical technology company that specializes in orthopedic implants, surgical products, and digital solutions designed to improve mobility and musculoskeletal health. Headquartered in Warsaw, Indiana, the company traces its roots back to 1927 and operates in more than 100 countries.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and Zimmer Biomet fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical devices industry. Its competitive advantages stem from its strong position as one of the world's largest orthopedic device manufacturers, supported by a broad portfolio of hip, knee, shoulder, and trauma implants, as well as advanced surgical technologies. The company benefits from well-established relationships with hospitals and surgeons, a globally recognized brand, and significant scale that supports research, innovation, and distribution.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.